Graham Lumsden
Chief Executive Officer at BioMarck Pharmaceuticals Ltd.
Graham Lumsden active positions
Companies | Position | Start | End |
---|---|---|---|
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases. | Corporate Officer/Principal | - | - |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Chief Executive Officer | 2021-01-04 | - |
President | 2021-01-04 | - |
Career history of Graham Lumsden
Former positions of Graham Lumsden
Companies | Position | Start | End |
---|---|---|---|
MOTIF BIO PLC | Director/Board Member | 2015-01-20 | 2021-06-13 |
Chief Executive Officer | 2015-01-20 | 2020-05-03 | |
Tiemed LLC | Chief Executive Officer | 2011-12-31 | 2013-12-31 |
Carnethy Consulting LLC | Corporate Officer/Principal | 2011-12-31 | 2013-12-31 |
MERCK & CO., INC. | Corporate Officer/Principal | 1984-12-31 | 2000-12-31 |
IMMUTEP LIMITED | Director/Board Member | - | - |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Training of Graham Lumsden
The Royal School of Veterinary Studies | Undergraduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 4 |
Australia | 2 |
Operational
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
IMMUTEP LIMITED | Health Technology |
Private companies | 6 |
---|---|
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Health Technology |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases. | Commercial Services |
Motif Bio Plc
Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
Tiemed LLC | |
Carnethy Consulting LLC | |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Graham Lumsden
- Experience